Amryt to report q2 2022 results on august 4, 2022

Dublin, ireland, and boston ma, july 21 , 202 2 , amryt (nasdaq: amyt) a global, commercial-stage biopharmaceutical company dedicated to acquiring, developing and commercializing novel treatments for rare diseases, today announces that its unaudited financial results for the second quarter 2022 will be released on thursday , august 4 , 202 2 at 0700 e t/1200 bst.

AMYT Ratings Summary

AMYT Quant Ranking